Heregger, Ronald
Greil, Richard
Funding for this research was provided by:
Paracelsus Medical University
Article History
Received: 29 May 2023
Accepted: 10 July 2023
First Online: 28 August 2023
Conflict of interest
: R. Heregger declares travel, accommodations, and expenses from Pharmamar. R. Greil declares honoraria, and consulting or advisory role for Celgene, Roche, Merck, Takeda, AstraZeneca, Novartis, Amgen, BMS, MSD, Sandoz, AbbVie, Gilead, and Daiichi Sankyo, and travel, accommodations and expenses from Roche, Amgen, Janssen, AstraZeneca, Novartis, MSD, Celgene, Gilead, BMS, and AbbVie.